Ocular Motility Disorders
Welcome,         Profile    Billing    Logout  
 10 Companies   7 Products   7 Products   16 Mechanisms of Action   0 Trials   106 News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Products
 012345678910
            
                                                                                                      
            
Glutamate receptor antag           
          
            
            
NMDAR antag           
          
            
            
AChE inhib           
          
            
            
Acetylcholine inhib           
          
            
            
BChE inhib           
          
            
            
CD20 inhib           
          
            
            
CD20 inhib           
          
            
            
CD20 inhib           
          
            
            
MAOB inhib           
          
            
            
NGF stim           
          
            
            
Na+ channel antag           
          
            
            
Serotonin 1D receptor agon           
          
            
            
Substance P release inhib           
          
            
            
Tubulin polymerization inhib           
          
            
            
Tubulin polymerization inhib           
          
            
            
Voltage-gated sodium channel inhib